| Dr Terry Curtis Fultz, DO | |
|
908 W 4th North St, Morristown, TN 37814-3894 | |
| (423) 492-9000 | |
| Not Available |
| Full Name | Dr Terry Curtis Fultz |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 908 W 4th North St, Morristown, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285155531 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morristown Hamblen Hospital Association | Morristown, TN | Hospital |
| Wellmont Holston Valley Medical Center | Kingsport, TN | Hospital |
| Johnston Memorial Hospital | Abingdon, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Coverage Corp | 3072412592 | 364 |
| Western Virginia Regional Emergency Physicians Llc | 4183991227 | 79 |
News Archive
Research conducted by Lindsay R. Sklar, M.D., Christopher T. Burnett, M.D., F.A.A.D., Jill S. Waibel, M.D., F.A.A.D., Ronald L. Moy, M.D., F.A.A.D., and David M. Ozog, M.D., F.A.A.D., was selected as Editor's Choice for the April 2014 issue of Lasers in Surgery and Medicine.
A new study finds that in regions where indigenous Australians most readily accepted a government incentive to lower drug copayments, hospitalizations to treat the population's chronic conditions declined by 40 percent in just two years.
UK adults could take steps to avoid having a stroke if more people knew the top risk factors for stroke and made one small change to their lifestyle, the UK's leading stroke charity says.
Esperion Therapeutics, a privately held biopharmaceutical company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that TransGenRx, a global leader in transgenic technology, will produce protein-based therapeutics to be used in the company's research efforts targeting HDL therapies for the treatment of cardio-metabolic disease.
A new study deals with the evaluation of adaptive immune response to COVID-19 vaccination in candidates who have recovered from SARS-CoV-2 infection.
› Verified 7 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20050207000666 |
News Archive
Research conducted by Lindsay R. Sklar, M.D., Christopher T. Burnett, M.D., F.A.A.D., Jill S. Waibel, M.D., F.A.A.D., Ronald L. Moy, M.D., F.A.A.D., and David M. Ozog, M.D., F.A.A.D., was selected as Editor's Choice for the April 2014 issue of Lasers in Surgery and Medicine.
A new study finds that in regions where indigenous Australians most readily accepted a government incentive to lower drug copayments, hospitalizations to treat the population's chronic conditions declined by 40 percent in just two years.
UK adults could take steps to avoid having a stroke if more people knew the top risk factors for stroke and made one small change to their lifestyle, the UK's leading stroke charity says.
Esperion Therapeutics, a privately held biopharmaceutical company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that TransGenRx, a global leader in transgenic technology, will produce protein-based therapeutics to be used in the company's research efforts targeting HDL therapies for the treatment of cardio-metabolic disease.
A new study deals with the evaluation of adaptive immune response to COVID-19 vaccination in candidates who have recovered from SARS-CoV-2 infection.
› Verified 7 days ago
| Entity Name | Tri-cities Regional Emergency Physicians, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063950046 PECOS PAC ID: 3678859477 Enrollment ID: O20170410002399 |
News Archive
Research conducted by Lindsay R. Sklar, M.D., Christopher T. Burnett, M.D., F.A.A.D., Jill S. Waibel, M.D., F.A.A.D., Ronald L. Moy, M.D., F.A.A.D., and David M. Ozog, M.D., F.A.A.D., was selected as Editor's Choice for the April 2014 issue of Lasers in Surgery and Medicine.
A new study finds that in regions where indigenous Australians most readily accepted a government incentive to lower drug copayments, hospitalizations to treat the population's chronic conditions declined by 40 percent in just two years.
UK adults could take steps to avoid having a stroke if more people knew the top risk factors for stroke and made one small change to their lifestyle, the UK's leading stroke charity says.
Esperion Therapeutics, a privately held biopharmaceutical company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that TransGenRx, a global leader in transgenic technology, will produce protein-based therapeutics to be used in the company's research efforts targeting HDL therapies for the treatment of cardio-metabolic disease.
A new study deals with the evaluation of adaptive immune response to COVID-19 vaccination in candidates who have recovered from SARS-CoV-2 infection.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terry Curtis Fultz, DO 908 W 4th North St, Morristown, TN 37814-3894 Ph: (423) 492-9000 | Dr Terry Curtis Fultz, DO 908 W 4th North St, Morristown, TN 37814-3894 Ph: (423) 492-9000 |
News Archive
Research conducted by Lindsay R. Sklar, M.D., Christopher T. Burnett, M.D., F.A.A.D., Jill S. Waibel, M.D., F.A.A.D., Ronald L. Moy, M.D., F.A.A.D., and David M. Ozog, M.D., F.A.A.D., was selected as Editor's Choice for the April 2014 issue of Lasers in Surgery and Medicine.
A new study finds that in regions where indigenous Australians most readily accepted a government incentive to lower drug copayments, hospitalizations to treat the population's chronic conditions declined by 40 percent in just two years.
UK adults could take steps to avoid having a stroke if more people knew the top risk factors for stroke and made one small change to their lifestyle, the UK's leading stroke charity says.
Esperion Therapeutics, a privately held biopharmaceutical company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that TransGenRx, a global leader in transgenic technology, will produce protein-based therapeutics to be used in the company's research efforts targeting HDL therapies for the treatment of cardio-metabolic disease.
A new study deals with the evaluation of adaptive immune response to COVID-19 vaccination in candidates who have recovered from SARS-CoV-2 infection.
› Verified 7 days ago
Dr. Georgia K Tye, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 726 Mcfarland St, Morristown, TN 37814 Phone: 423-522-6560 Fax: 423-587-4552 | |
Valerie A Hart, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2351 Windswept Way, Morristown, TN 37814 Phone: 937-631-0160 | |
Probo H Castillo, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 908 W 4th North St, Morristown, TN 37814 Phone: 423-586-4234 Fax: 865-985-7077 | |
Dr. James Zheng Yu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 908 W 4th North St, Morristown, TN 37814 Phone: 423-586-4231 Fax: 865-291-3228 | |
Stephen T Gore, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 908 W 4th North St, Morristown, TN 37814 Phone: 423-586-4231 Fax: 865-291-3228 | |
Charlene A Doyle, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 908 W 4th North St, Morristown, TN 37814 Phone: 423-586-4231 Fax: 865-985-7077 |